Detalhe da pesquisa
1.
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
Clin Exp Rheumatol
; 36 Suppl 113(4): 146-149, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30277862
2.
Short and medium-term outcomes in individuals hospitalized with acute myocardial infarction and multiple chronic conditions: The Worcester heart attack study.
J Multimorb Comorb
; 14: 26335565241242279, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549712
3.
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
Arthritis Rheumatol
; 70(4): 566-577, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29245183